LBPH
Income statement / Annual
Last year (2023), Longboard Pharmaceuticals, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Longboard Pharmaceuticals, Inc.'s net income was -$54.42 M.
See Longboard Pharmaceuticals, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$5,000.00 |
$5,000.00 |
$1,000.00 |
$0.00 |
| Gross Profit |
-$5,000.00 |
-$5,000.00 |
-$1,000.00 |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$43.75 M
|
$34.64 M
|
$19.77 M
|
$4.63 M
|
| General & Administrative
Expenses |
$13.01 M
|
$10.16 M
|
$8.07 M
|
$9.77 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$13.01 M
|
$10.16 M
|
$8.07 M
|
$9.77 M
|
| Other Expenses |
$0.00 |
$16,000.00 |
-$22,000.00 |
$0.00 |
| Operating Expenses |
$56.76 M |
$44.80 M |
$27.84 M |
$14.40 M |
| Cost And Expenses |
$56.76 M |
$44.80 M |
$27.84 M |
$14.40 M |
| Interest Income |
$2.41 M |
$837,000.00 |
$64,000.00 |
$0.00 |
| Interest Expense |
$0.00 |
$837,000.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$5,000.00
|
$5,000.00
|
$1,000.00
|
$7.00 M
|
| EBITDA |
-$56.75 M
|
-$44.79 M
|
-$27.84 M
|
-$14.40 M
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$2.34 M
|
$853,000.00
|
$42,000.00
|
$0.00
|
| Income Before Tax |
-$54.42 M |
-$43.95 M |
-$27.80 M |
-$14.40 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00 |
-$853,000.00 |
-$64,000.00 |
-$14,400.00 |
| Net Income |
-$54.42 M |
-$43.09 M |
-$27.73 M |
-$14.40 M |
| Net Income Ratio |
0 |
0 |
0 |
0 |
| EPS |
-2.39 |
-2.51 |
-1.62 |
-0.82 |
| EPS Diluted |
-2.39 |
-2.51 |
-1.62 |
-0.82 |
| Weighted Average Shares
Out |
$22.73 M
|
$17.15 M
|
$17.07 M
|
$17.67 M
|
| Weighted Average Shares
Out Diluted |
$22.73 M
|
$17.15 M
|
$17.07 M
|
$17.67 M
|
| Link |
|
|
|
|
